王小川隔空回应张文宏

Recently, Wang Xiaochuan, founder of Baichuan Intelligence, indirectly responded to earlier remarks by Dr. Zhang Wenhong, Director of the Department of Infectious Diseases at Huashan Hospital affiliated with Fudan University, regarding the impact of artificial intelligence (AI) on healthcare. Dr. Zhang had previously stated that while AI can enhance efficiency, it cannot replace clinicians’ judgment or humanistic care. Wang expressed agreement with this core perspective, emphasizing that AI is not meant to replace doctors but rather to serve as a ‘super assistant’ that empowers the healthcare system. He noted that current large language models are already significantly improving efficiency in areas such as diagnostic support, medical record management, and drug discovery, thereby reducing physicians’ administrative burdens and allowing them to focus more on patient communication and complex decision-making. Wang also highlighted the need for close collaboration between the medical and tech communities to ensure the ethical, safe, and equitable integration of AI into clinical settings. He called for interdisciplinary cooperation to establish shared technical standards and ethical guidelines. This exchange—though conducted separately—reflects a thoughtful, balanced view from both technology and medicine on AI’s role and signals that human-AI collaboration will be central to the future of healthcare.

近日,百川智能创始人王小川在一次公开活动中隔空回应了复旦大学附属华山医院感染科主任张文宏此前关于人工智能(AI)对医疗行业影响的言论。张文宏曾表示,AI虽能提升效率,但无法替代医生的临床判断和人文关怀。对此,王小川表示认同其核心观点,同时强调AI并非要取代医生,而是作为‘超级助手’赋能医疗体系。他指出,当前大模型技术已能在辅助诊断、病历整理、药物研发等环节显著提升效率,减轻医生负担,让医生更专注于与患者的沟通和复杂决策。王小川还提到,未来AI与医疗的深度融合,需要医学界与科技界紧密协作,共同制定伦理规范和技术标准。他呼吁建立跨学科合作机制,确保AI在医疗场景中的安全、可靠与公平应用。这场隔空对话体现了科技与医学两大领域对AI角色的理性思考,也预示着人机协同将成为未来医疗发展的主流方向。

原创文章,作者:admin,如若转载,请注明出处:https://avine.cn/19681.html

(0)
上一篇 2026年1月22日 下午12:04
下一篇 2026年1月22日 下午12:05

相关推荐